
BMS-189453
CAS No. 166977-43-1
BMS-189453 ( BMS189453 | BMS453 )
产品货号. M12547 CAS No. 166977-43-1
BMS-189453 (BMS189453, BMS453) 是一种合成类维生素A,可作为 RARβ 的激动剂以及 RARα 和 RARγ 的拮抗剂。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥786 | 有现货 |
![]() ![]() |
10MG | ¥1320 | 有现货 |
![]() ![]() |
25MG | ¥2940 | 有现货 |
![]() ![]() |
50MG | ¥4398 | 有现货 |
![]() ![]() |
100MG | ¥6334 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称BMS-189453
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述BMS-189453 (BMS189453, BMS453) 是一种合成类维生素A,可作为 RARβ 的激动剂以及 RARα 和 RARγ 的拮抗剂。
-
产品描述BMS-189453 (BMS189453, BMS453) is a synthetic retinoid that acts as an agonist of RARβ and an antagonist of RARα and RARγ; binds to RAR receptors and transrepresses AP-1, inhibits the growth of normal breast cells (HMEC and 184) and T47D breast cancer cells; increases p21, decrease CDK2 kinase activity, which in turn leads to hypophosphorylation of Rb and G1 arrest. Rheumatoid Arthritis Discontinued.
-
体外实验BMS453 (1 μM; 11 hours; 184 and HMEC cells) treatment inhibits the proliferation of normal breast cell growth without significantly inducing apoptosis.BMS453 (1 μM; 5 days; 184 and HMEC cells) treatment inhibits normal breast cell proliferation by causing G1 arrest.BMS453 (1 μM; 24-72 hours; 184 cells) treatment induces Rb hypophosphorylation and decrease CDK2 kinase activity. BMS453 increases total p21 protein levels and CDK2-bound p21 protein, but does not change CDK4-bound p21. BMS453 inhibits breast cell growth predominantly through the induction of active TGFβ.Cell Proliferation Assay Cell Line:Normal human mammary epithelial cells (184 and HMEC) Concentration:1 μMIncubation Time:11 hours Result:Inhibited 3H-thymidine uptake in normal breast cells (184 and HMEC) by 40 %.Cell Cycle Analysis Cell Line:Normal human mammary epithelial cells (184 and HMEC) Concentration:1 μMIncubation Time:5 days Result:Increased the proportion of cells in G0/G1 phase and decreased the proportion of cells in S phase.Western Blot Analysis Cell Line:184 cells Concentration:1 μM Incubation Time:24 hours, 48 hours, 72 hours Result:Induced Rb hypophosphorylation and decrease CDK2 kinase activity.
-
体内实验——
-
同义词BMS189453 | BMS453
-
通路Nuclear Receptor/Transcription Factor
-
靶点RAR/RXR
-
受体RAR/RXR
-
研究领域Inflammation/Immunology
-
适应症Rheumatoid Arthritis
化学信息
-
CAS Number166977-43-1
-
分子量380.5
-
分子式C27H24O2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 16.67 mg/mL (43.81 mM)
-
SMILESO=C(O)C1=CC=C(/C=C/C2=CC=C3C(C)(C)CC=C(C4=CC=CC=C4)C3=C2)C=C1
-
化学全称Benzoic acid, 4-[(1E)-2-[5,6-dihydro-5,5-dimethyl-8-(phenylethynyl)-2-naphthalenyl]ethenyl]- (9CI)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Chen JY, et al. EMBO J. 1995 Mar 15;14(6):1187-97.
2. Yang L, et al. Oncogene. 2001 Nov 29;20(55):8025-35.
3. Yang L, et al. Breast Cancer Res Treat. 1999 Aug;56(3):277-91.